Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteria

1 Jul 2003

Abstract excerpt

The success or failure of antimicrobial therapy in bacterial and fungal infections is predicted ideally by antimicrobial susceptibility testing (AST), in which microorganisms are divided into treatable and non-treatable categories on the basis of MIC breakpoints. In Europe, the categorization was traditionally a clinical one and it was made irrespective of whether or not the organism harboured resistance...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibiotic Resistance in Bacteria
Share to Antibiotics Pharmacokinetics and Efficacy
Share to Bacterial Identification and Susceptibility Testing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 12837738
DOI: 10.1093/jac/dkg312

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteriaPMID 12837738Read ↗

Susceptibility testing methods, resistance and breakpoints: what do these terms really mean?Semantic proximity Read ↗

The 2014 Garrod Lecture: EUCAST – are we heading towards international agreement?Semantic proximity Read ↗

Critical Assessment of Issues Applicable to Development of Antimicrobial Susceptibility Testing BreakpointsSemantic proximity Read ↗

Antimicrobial susceptibility testing breakpoints and methods from BSAC to EUCASTSemantic proximity Read ↗

Establishing MIC breakpoints and the interpretation of <i>in vitro</i> susceptibility testsSemantic proximity Read ↗

Setting and Revising Antibacterial Susceptibility BreakpointsSemantic proximity Read ↗

Setting Antimicrobial Susceptibility Testing Breakpoints: A Primer for Pediatric Infectious Diseases Specialists on the Clinical and Laboratory Standards Institute ApproachSemantic proximity Read ↗

Wild-type distributions of minimum inhibitory concentrations and epidemiological cut-off values—laboratory and clinical utilitySemantic proximity Read ↗

Amoxicillin-Clavulanate Breakpoints AgainstEnterobacterales: Rationale for Revision by the Clinical and Laboratory Standards InstituteSemantic proximity Read ↗

Breaking Down the Breakpoints: Rationale for the 2022 Clinical and Laboratory Standards Institute Revised Piperacillin-Tazobactam Breakpoints Against EnterobacteralesSemantic proximity Read ↗

A Long Journey from Minimum Inhibitory Concentration Testing to Clinically Predictive Breakpoints: Deterministic and Probabilistic Approaches in Deriving BreakpointsSemantic proximity Read ↗

Updating breakpoints in the United States: a summary from the ASM Clinical Microbiology Open 2022Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.